Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
Crossref DOI link: https://doi.org/10.1038/s41598-021-01263-w
Published Online: 2021-11-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quan, Quan
Liao, Qianqian
Yin, Wanchun
Zhou, Shuwei
Gong, Sainan
Mu, Xiaoling
Text and Data Mining valid from 2021-11-04
Version of Record valid from 2021-11-04
Article History
Received: 24 June 2021
Accepted: 25 October 2021
First Online: 4 November 2021
Competing interests
: The authors declare no competing interests.